SCHEMBL17257020

SCHEMBL17257020

N#CC1CCC(=NOS(=O)(=O)c2ccccc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPK1 P28482 4/20 0.41
▸ ALDH1A1 P00352 7/20 0.39
▸ MAPT P10636 7/20 0.39
▸ NPSR1 Q6W5P4 6/20 0.39
▸ MPI P34949 5/20 0.39
▸ XBP1 P17861 4/20 0.39
▸ HSP90AA1 P07900 4/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ APLNR P35414 2/20 0.38
▸ LMNA P02545 4/20 0.37
▸ RAB9A P51151 4/20 0.37
▸ S1PR2 O95136 3/20 0.37
▸ PKM P14618 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ OPRM1 P35372 1/20 0.37
▸ OPRD1 P41143 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17257017 1.00 MEN1 (0.43) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17257624 0.91 MEN1 (0.41) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17257625 0.91 MEN1 (0.41) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17256850 0.90 APLNR (0.42) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17256914 0.90 APLNR (0.42) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17256916 0.90 APLNR (0.42) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17256852 0.90 APLNR (0.42) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17257037 0.86 MEN1 (0.44) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17257039 0.86 MEN1 (0.44) MEN1KMT2AMAPK1ALDH1A1MAPT
SCHEMBL17257113 0.85 MEN1 (0.43) MEN1KMT2AMAPK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10030083-B2 Polymers functionalized with protected oxime compounds containing a cyano group BRIDGESTONE CORPORATION (JP) 2018-07-24 — — US claimed
EP-3143055-A2 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP Bridgestone Corporation (JP) 2017-03-22 — — EP claimed
US-20150329655-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP BRIDGESTONE CORPORATION (JP) 2015-11-19 — — US claimed
WO-2015175280-A2 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP BRIDGESTONE CORPORATION (JP) 2015-11-19 — — WO claimed
US-10030083-B2 Polymers functionalized with protected oxime compounds containing a cyano group BRIDGESTONE CORPORATION (JP) 2018-07-24 — — US disclosed
US-20150329655-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP BRIDGESTONE CORPORATION (JP) 2015-11-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10030083-B2 Polymers functionalized with protected oxime compounds containing a cyano group PAM, PPOX, MB MEN1 3302/4885KMT2A 2399/4885MAPK1 1603/4885
US-20150329655-A1 POLYMERS FUNCTIONALIZED WITH PROTECTED OXIME COMPOUNDS CONTAINING A CYANO GROUP PAM, PPOX, MB MEN1 3302/4885KMT2A 2399/4885MAPK1 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback